ESPN🎵 Jay-Z to headline Super Bowl halftime Super Bowl LXI: Feb. 14 on ESPN networks From 'no' to halftime show: The clues behind Jay-Z's Super Bowl nodESPN DeportesMaxi Rodríguez estuvo cerca de llegar al AméricaBollywood HungamaSCOOP: Salman Khan’s Maatrubhumi STILL awaits CBFC screening despite government clearance; November 13 release eyed to avoid clashes with Yeh Prem Mol Liya, EethaThe Jerusalem PostKnife-wielding man detained after approaching Democrats' Golan during Election Day tour in Tel AvivInquirerBarbers: What’s the exact extent of VP Duterte’s business interests?RapplerWith El Niño, 2026-2027 northeast monsoon may not be as coldZDF heuteEntdecken Sie das ZDF-NachrichtenstudioWirtualna PolskaKarol Nawrocki będzie zeznawał w sądzie. Jest terminMyJoyOnlineKofi Hayford shines as MC of M.anifest’s ‘Nowhere Cool’ at 10 celebrationComplete SportsEUROMATCH NPFL: Kun Khalifat Appoint Nwabuwah As Co-ordinator For 2026/27 SeasonVilaWebLa Comissió Europea proposa d’ampliar el mandat de Frontex per deportar migrants des de fora de la UEConsequenceFoo Fighters Launch Week-Long Takeover of Kimmel with Performance of “Window”
KioskNews
The Daily Newsstand · Free, Always
Tuesday, October 27, 2026
Language
Seeking Alpha·United States·

Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.02, revenue of $0.23M beats by $0.02M

Translate

Deepa Sarvaiya

  • Nautilus Biotechnology press release (NAUT): Q3 GAAP EPS of -$0.12 beats by $0.02.
  • Revenue of $0.23M beats by $0.02M.
  • Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue from the Company’s activities related to the grant awarded from The Michael J. Fox Foundation during the period, and service revenue for the sales of services under the Iterative Mapping Early Access Program.

Recommended For You

Register for free to keep reading.

Create a free account to get unlimited breaking news and alerts when your stocks move.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.